Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasonpropionat "nordic prime" 25+250 mikrog/dosis inhalationsspray, suspension
nordic prime aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog/dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasonpropionat "cipla" 25+125 mikrog/dosis inhalationsspray, suspension
cipla europe nv - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog/dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasonpropionat "cipla" 25+250 mikrog/dosis inhalationsspray, suspension
cipla europe nv - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog/dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasonpropionat cipla 25+250 mikrog/dosis inhalationsspray, suspension
2care4 aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog/dosis
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
airexar spiromax
teva b.v. - salmeterol, fluticasonpropionat - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - airexar spiromax er indiceret til brug kun hos voksne i alderen 18 år og ældre. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. kronisk obstruktiv lungesygdom (kol)airexar spiromax er indiceret til symptomatisk behandling af patienter med kol med fev1.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasone "zentiva" 25+50 mikrog./dosis inhalationsspray, suspension
zentiva k.s. - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+50 mikrog./dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasone "neutec" 50+100 mikrog/dosis inhalationspulver, afdelt
neutec inhaler ireland limited - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+100 mikrog/dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasone "neutec" 50+500 mikrog/dosis inhalationspulver, afdelt
neutec inhaler ireland limited - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrog/dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasone "zentiva" 25+125 mikrog./dosis inhalationsspray, suspension
zentiva k.s. - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
salmeterol/fluticasone "zentiva" 25+250 mikrog./dosis inhalationsspray, suspension
zentiva k.s. - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis